Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PTH,Parathyroid hormone,Inverse variance weighted,10,1.13 [1.07-1.19],4.78578279665223e-06,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,BAMBI,BMP and activin membrane-bound inhibitor homolog,Inverse variance weighted,10,1.08 [1.03-1.13],0.000802965786484761,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CDHR1,Cadherin-related family member 1,Inverse variance weighted,10,1.19 [1.06-1.34],0.00276239964827415,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,BGLAP,Osteocalcin,Inverse variance weighted,10,1.06 [1.02-1.11],0.00748856511079789,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PCDH12,Protocadherin-12,Inverse variance weighted,10,1.2 [1.05-1.37],0.00793967459113003,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CHAD,Chondroadherin,Inverse variance weighted,10,1.07 [1.02-1.12],0.00802485370661805,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,10,0.94 [0.9-0.99],0.00837543782730812,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MEPE,Matrix extracellular phosphoglycoprotein,Inverse variance weighted,10,1.05 [1.01-1.1],0.0132088349686333,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,10,1.06 [1.01-1.11],0.0138152412180078,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KLK6,Kallikrein-6,Inverse variance weighted,10,0.93 [0.88-0.99],0.0146341278069201,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,0.95 [0.91-0.99],0.0194711929221372,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CA9,Carbonic anhydrase 9,Inverse variance weighted,10,1.05 [1.01-1.1],0.0218069796451439,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,10,0.95 [0.91-0.99],0.0222025376228132,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPP1,Osteopontin,Inverse variance weighted,10,1.06 [1.01-1.12],0.0258300266087701,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,10,0.96 [0.92-1],0.0294669552783945,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CTSV,Cathepsin L2,Inverse variance weighted,10,0.96 [0.92-1],0.0321372536914544,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,10,0.96 [0.92-1],0.0323418166994724,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SNCG,Gamma-synuclein,Inverse variance weighted,10,0.96 [0.92-1],0.0332334222379108,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ENDOU,Poly(U)-specific endoribonuclease,Inverse variance weighted,10,0.95 [0.92-1],0.0333331414880336,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DKK4,Dickkopf-related protein 4,Inverse variance weighted,10,1.05 [1-1.1],0.0342865110632895,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,10,0.95 [0.91-1],0.0366951764244359,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CDH15,Cadherin-15,Inverse variance weighted,10,1.06 [1-1.12],0.0374609340939002,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,OMD,Osteomodulin,Inverse variance weighted,10,1.06 [1-1.11],0.0439479317249577,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,10,1.06 [1-1.11],0.0442077898437513,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DMP1,Dentin matrix acidic phosphoprotein 1,Inverse variance weighted,10,1.06 [1-1.13],0.0450218124514458,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,10,0.96 [0.91-1],0.0460377549374916,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FSTL3,Follistatin-related protein 3,Inverse variance weighted,10,0.95 [0.91-1],0.0525995127218412,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PCDH17,Protocadherin-17,Inverse variance weighted,10,1.04 [1-1.09],0.0541032765206002,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PCDHB15,Protocadherin beta-15,Inverse variance weighted,10,1.07 [1-1.14],0.0543441166928893,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,0.95 [0.91-1],0.0543710931126778,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CX3CL1,Fractalkine,Inverse variance weighted,10,0.96 [0.92-1],0.0556368625736578,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,10,1.04 [1-1.09],0.0557431445347089,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CDH6,Cadherin-6,Inverse variance weighted,10,1.04 [1-1.09],0.0557786483863426,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,Inverse variance weighted,10,1.05 [1-1.11],0.0564657756334421,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCN3,CCN family member 3,Inverse variance weighted,10,0.94 [0.89-1],0.0571241237392454,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,10,0.96 [0.92-1],0.0576034274168409,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DLK1,Protein delta homolog 1,Inverse variance weighted,10,0.96 [0.92-1],0.0588025897831591,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PALM2,Paralemmin-2,Inverse variance weighted,10,0.96 [0.92-1],0.0610077327852777,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,10,0.93 [0.87-1],0.061041433789614,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCL11,Eotaxin,Inverse variance weighted,10,1.05 [1-1.11],0.0611277696907011,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CTSL,Cathepsin L1,Inverse variance weighted,10,0.95 [0.9-1],0.0612323874232308,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PGF,Placenta growth factor,Inverse variance weighted,10,0.96 [0.91-1],0.0617967736245297,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,10,0.96 [0.92-1],0.0630193745823784,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,10,0.96 [0.93-1],0.0760027392392587,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,1.05 [1-1.1],0.077747688053781,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD99,CD99 antigen,Inverse variance weighted,10,1.03 [1-1.07],0.0786745063070834,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,10,0.96 [0.92-1.01],0.0812779972246374,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,10,0.96 [0.92-1],0.0824307329585775,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,10,1.04 [1-1.08],0.0835059543162938,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,OGN,Mimecan,Inverse variance weighted,10,0.96 [0.91-1.01],0.0837497337027492,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,10,0.96 [0.93-1.01],0.0851264157132902,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CTRB1,Chymotrypsinogen B,Inverse variance weighted,10,1.04 [0.99-1.09],0.0851814040641858,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,10,1.05 [0.99-1.11],0.0854345319663724,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,B2M,Beta-2-microglobulin,Inverse variance weighted,10,0.96 [0.92-1.01],0.090318051932079,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SERPINB8,Serpin B8,Inverse variance weighted,10,0.97 [0.94-1],0.090997700009131,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FBLN2,Fibulin-2,Inverse variance weighted,10,0.96 [0.92-1.01],0.0920915973230011,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,10,0.95 [0.9-1.01],0.0926328081145774,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DPT,Dermatopontin,Inverse variance weighted,10,0.97 [0.93-1.01],0.0947221028718662,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,0.97 [0.93-1.01],0.0984022929316485,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,Inverse variance weighted,10,0.96 [0.91-1.01],0.0993810728547292,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL15,Interleukin-15,Inverse variance weighted,10,0.96 [0.92-1.01],0.101059523110414,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,0.96 [0.92-1.01],0.105802369511673,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,10,0.96 [0.92-1.01],0.112161274851432,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,10,0.95 [0.88-1.01],0.112200668486544,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,10,0.97 [0.92-1.01],0.112735284640853,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,Inverse variance weighted,10,1.03 [0.99-1.07],0.116067977720247,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,10,0.97 [0.93-1.01],0.117791578087806,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CST6,Cystatin-M,Inverse variance weighted,10,0.95 [0.89-1.01],0.121087230187352,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCN4,CCN family member 4,Inverse variance weighted,10,0.97 [0.93-1.01],0.121541784899984,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCN5,CCN family member 5,Inverse variance weighted,10,0.96 [0.92-1.01],0.124134571704849,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CHRDL1,Chordin-like protein 1,Inverse variance weighted,10,0.96 [0.9-1.01],0.124589155940649,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,10,0.97 [0.93-1.01],0.12522538993887,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,BCL2L15,Bcl-2-like protein 15,Inverse variance weighted,10,1.03 [0.99-1.08],0.125554242697811,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,10,0.96 [0.92-1.01],0.139946546938469,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,10,1.03 [0.99-1.08],0.140025090993647,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EFNB2,Ephrin-B2,Inverse variance weighted,10,1.03 [0.99-1.08],0.140305863487172,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,10,0.96 [0.91-1.01],0.140592774186487,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LGALS3,Galectin-3,Inverse variance weighted,10,0.97 [0.94-1.01],0.150053531278304,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LMNB2,Lamin-B2,Inverse variance weighted,10,0.96 [0.92-1.01],0.153945553597402,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CA14,Carbonic anhydrase 14,Inverse variance weighted,10,1.03 [0.99-1.08],0.161180615230473,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,AMBP,Protein AMBP,Inverse variance weighted,10,0.97 [0.93-1.01],0.161388062395239,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KLK4,Kallikrein-4,Inverse variance weighted,10,0.98 [0.94-1.01],0.161760258220558,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,F3,Tissue factor,Inverse variance weighted,10,0.97 [0.93-1.01],0.16654390743747,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,10,1.03 [0.99-1.08],0.166737665473819,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,10,1.03 [0.99-1.08],0.168099947343491,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KLRF1,Killer cell lectin-like receptor subfamily F member 1,Inverse variance weighted,10,1.03 [0.99-1.08],0.168483199851677,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FABP6,Gastrotropin,Inverse variance weighted,10,1.03 [0.99-1.08],0.168900798601336,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,10,0.97 [0.93-1.01],0.169951846152762,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,COL1A1,Collagen alpha-1(I) chain,Inverse variance weighted,10,1.03 [0.99-1.08],0.170085841005634,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,10,0.97 [0.93-1.01],0.171132370286809,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD302,CD302 antigen,Inverse variance weighted,10,0.95 [0.89-1.02],0.171617523587801,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,10,0.97 [0.93-1.01],0.175443603250825,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,VWC2,Brorin,Inverse variance weighted,10,0.96 [0.91-1.02],0.177490058864307,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CKB,Creatine kinase B-type,Inverse variance weighted,10,1.03 [0.99-1.08],0.179711523304619,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NXPH3,Neurexophilin-3,Inverse variance weighted,10,1.03 [0.98-1.09],0.183051950984839,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RGMA,Repulsive guidance molecule A,Inverse variance weighted,10,1.03 [0.98-1.08],0.186354869587621,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPINK2,Serine protease inhibitor Kazal-type 2,Inverse variance weighted,10,0.98 [0.94-1.01],0.189686194720776,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,10,0.97 [0.93-1.02],0.19294859723082,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MOG,Myelin-oligodendrocyte glycoprotein,Inverse variance weighted,10,0.97 [0.93-1.02],0.195014314043166,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CST3,Cystatin-C,Inverse variance weighted,10,0.97 [0.93-1.02],0.19988248598368,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PPL,Periplakin,Inverse variance weighted,10,1.04 [0.98-1.09],0.200179366500114,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,10,0.97 [0.92-1.02],0.204638329175764,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,10,0.97 [0.93-1.02],0.206221540923435,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,OCLN,Occludin,Inverse variance weighted,10,0.97 [0.92-1.02],0.208343489727017,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,10,0.97 [0.92-1.02],0.21222793778289,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,HSPB6,Heat shock protein beta-6,Inverse variance weighted,10,0.98 [0.94-1.01],0.214013313234914,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,10,0.97 [0.93-1.02],0.215685608097288,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,10,0.97 [0.93-1.02],0.216614295896239,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,POF1B,Protein POF1B,Inverse variance weighted,10,1.03 [0.98-1.08],0.217561837055635,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,10,1.03 [0.98-1.08],0.220925402974966,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MB,Myoglobin,Inverse variance weighted,10,0.98 [0.94-1.01],0.223710224756577,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,10,1.03 [0.98-1.09],0.224954241494542,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,10,0.97 [0.93-1.02],0.225569358735947,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,10,0.97 [0.91-1.02],0.226866163293402,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CFC1,Cryptic protein,Inverse variance weighted,10,1.03 [0.98-1.09],0.226972019681091,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,UMOD,Uromodulin,Inverse variance weighted,10,0.98 [0.95-1.01],0.22896029664318,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SEMA3G,Semaphorin-3G,Inverse variance weighted,10,1.03 [0.98-1.07],0.231151829111506,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,10,0.97 [0.93-1.02],0.237711906486505,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KITLG,Kit ligand,Inverse variance weighted,10,1.03 [0.98-1.07],0.238048408496602,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,JAM3,Junctional adhesion molecule C,Inverse variance weighted,10,1.04 [0.97-1.11],0.240393437498057,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PNLIPRP1,Inactive pancreatic lipase-related protein 1,Inverse variance weighted,10,1.03 [0.98-1.07],0.243701266149212,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CDH3,Cadherin-3,Inverse variance weighted,10,0.97 [0.91-1.02],0.244210389109361,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,10,1.03 [0.98-1.07],0.245196635565782,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPINK6,Serine protease inhibitor Kazal-type 6,Inverse variance weighted,10,1.02 [0.98-1.07],0.247436268994531,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,10,0.97 [0.91-1.03],0.249585292435846,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD55,Complement decay-accelerating factor,Inverse variance weighted,10,0.98 [0.93-1.02],0.251475958894951,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,10,1.02 [0.99-1.05],0.252560657604956,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MXRA8,Matrix remodeling-associated protein 8,Inverse variance weighted,10,1.02 [0.98-1.07],0.258605816512898,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,10,0.98 [0.93-1.02],0.26233749227275,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,10,1.03 [0.98-1.07],0.263695352743998,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,0.96 [0.9-1.03],0.266764370623112,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD200,OX-2 membrane glycoprotein,Inverse variance weighted,10,1.03 [0.98-1.07],0.268710326756323,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CA12,Carbonic anhydrase 12,Inverse variance weighted,10,0.97 [0.93-1.02],0.269167971268574,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,10,0.96 [0.9-1.03],0.270820881637104,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,10,1.02 [0.98-1.06],0.271785674132419,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,Inverse variance weighted,10,1.04 [0.97-1.12],0.275476920618867,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GUCA2A,Guanylin,Inverse variance weighted,10,1.02 [0.98-1.07],0.276187701861,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,10,0.96 [0.89-1.03],0.276341827911981,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,10,0.98 [0.94-1.02],0.2800948917175,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,10,0.97 [0.91-1.03],0.280155914735357,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SDC1,Syndecan-1,Inverse variance weighted,10,0.98 [0.93-1.02],0.280537976116302,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,10,1.02 [0.98-1.07],0.280757982084935,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD7,T-cell antigen CD7,Inverse variance weighted,10,1.03 [0.98-1.08],0.281085729993632,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,10,1.03 [0.98-1.07],0.28745237422478,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,10,0.97 [0.92-1.03],0.289431263306076,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SCG2,Secretogranin-2,Inverse variance weighted,10,1.04 [0.97-1.11],0.291694015468862,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,10,1.02 [0.98-1.07],0.296910126131009,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GM2A,Ganglioside GM2 activator,Inverse variance weighted,10,0.98 [0.94-1.02],0.29777774697527,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,10,0.97 [0.93-1.02],0.300137168364138,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RGMB,RGM domain family member B,Inverse variance weighted,10,1.02 [0.98-1.07],0.301666617037625,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ZBTB17,Zinc finger and BTB domain-containing protein 17,Inverse variance weighted,10,0.98 [0.93-1.02],0.305352988186571,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPON2,Spondin-2,Inverse variance weighted,10,0.98 [0.93-1.02],0.306537238525944,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,JAM2,Junctional adhesion molecule B,Inverse variance weighted,10,0.98 [0.93-1.02],0.311766544772257,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TGFBR1,TGF-beta receptor type-1,Inverse variance weighted,10,1.03 [0.98-1.08],0.31569627244041,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DSC2,Desmocollin-2,Inverse variance weighted,10,1.02 [0.98-1.07],0.315806877145527,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,10,1.03 [0.98-1.08],0.317034314760083,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD27,CD27 antigen,Inverse variance weighted,10,1.03 [0.97-1.09],0.317355431285977,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KIRREL2,Kin of IRRE-like protein 2,Inverse variance weighted,10,1.02 [0.98-1.07],0.318627986699345,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NRP2,Neuropilin-2,Inverse variance weighted,10,1.02 [0.98-1.07],0.318942070467167,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,10,0.98 [0.94-1.02],0.319094274477358,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,VGF,Neurosecretory protein VGF,Inverse variance weighted,10,1.02 [0.98-1.07],0.319991714079875,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NPPC,C-type natriuretic peptide,Inverse variance weighted,10,0.97 [0.92-1.03],0.322178859653155,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TGFA,Protransforming growth factor alpha,Inverse variance weighted,10,0.97 [0.92-1.03],0.32415756025186,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,10,0.97 [0.91-1.03],0.32464446205102,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DKK3,Dickkopf-related protein 3,Inverse variance weighted,10,0.98 [0.93-1.02],0.326047052403626,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,10,0.98 [0.93-1.02],0.32746760080906,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,10,1.02 [0.98-1.06],0.32781498337567,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,10,0.97 [0.91-1.03],0.332623616955326,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,10,0.98 [0.94-1.02],0.33291810285013,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TCN2,Transcobalamin-2,Inverse variance weighted,10,1.02 [0.98-1.05],0.338645154824159,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,10,0.98 [0.94-1.02],0.340123870429111,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,STC1,Stanniocalcin-1,Inverse variance weighted,10,0.98 [0.94-1.02],0.345509568310589,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,10,1.03 [0.97-1.09],0.346556981460745,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PALM,Paralemmin-1,Inverse variance weighted,10,0.98 [0.94-1.02],0.347329016096088,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,10,0.98 [0.95-1.02],0.350022665572643,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MDK,Midkine,Inverse variance weighted,10,1.02 [0.98-1.07],0.350387830896941,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,10,0.98 [0.93-1.03],0.356335354464139,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CDSN,Corneodesmosin,Inverse variance weighted,10,0.97 [0.9-1.04],0.358301870573248,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FGF23,Fibroblast growth factor 23,Inverse variance weighted,10,1.03 [0.97-1.09],0.358801386085528,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DLL1,Delta-like protein 1,Inverse variance weighted,10,0.98 [0.94-1.02],0.359667558377664,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,10,0.99 [0.95-1.02],0.359899074441231,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,0.97 [0.92-1.03],0.359944923580946,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,10,1.02 [0.98-1.07],0.359975842892052,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,10,0.98 [0.94-1.02],0.362402516461151,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TMSB10,Thymosin beta-10,Inverse variance weighted,10,1.02 [0.98-1.07],0.367001021893357,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",Inverse variance weighted,10,0.97 [0.92-1.03],0.369867898047387,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,10,0.98 [0.94-1.02],0.372073436210662,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,BSG,Basigin,Inverse variance weighted,10,0.98 [0.94-1.02],0.374733665417151,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,10,0.98 [0.93-1.03],0.375184699731052,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,10,1.02 [0.98-1.07],0.37554813059605,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,Inverse variance weighted,10,1.02 [0.98-1.07],0.379314870142314,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,10,1.02 [0.98-1.06],0.384186447588941,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD300C,CMRF35-like molecule 6,Inverse variance weighted,10,0.98 [0.93-1.03],0.38461652565414,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,10,0.98 [0.92-1.03],0.39003790547309,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GP1BA,Platelet glycoprotein Ib alpha chain,Inverse variance weighted,10,1.03 [0.97-1.09],0.391012912278454,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,10,0.98 [0.94-1.02],0.391866008477134,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ADM,Pro-adrenomedullin,Inverse variance weighted,10,0.98 [0.93-1.03],0.392177514413268,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SHISA5,Protein shisa-5,Inverse variance weighted,10,0.98 [0.94-1.02],0.393791407914321,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,0.98 [0.93-1.03],0.400811265573798,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,10,0.98 [0.94-1.03],0.401483907239289,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,0.98 [0.92-1.03],0.402914539866473,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD93,Complement component C1q receptor,Inverse variance weighted,10,0.98 [0.93-1.03],0.405544628554811,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PI3,Elafin,Inverse variance weighted,10,0.97 [0.9-1.04],0.40612576337792,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DCN,Decorin,Inverse variance weighted,10,1.02 [0.98-1.06],0.408088056618545,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CSTB,Cystatin-B,Inverse variance weighted,10,1.02 [0.98-1.05],0.4102129612972,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,10,0.98 [0.95-1.02],0.410508498517483,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PLA2G1B,Phospholipase A2,Inverse variance weighted,10,1.02 [0.98-1.06],0.413008323749086,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FGF5,Fibroblast growth factor 5,Inverse variance weighted,10,1.02 [0.97-1.08],0.417278865899475,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,10,0.98 [0.94-1.03],0.417487194629746,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,10,1.02 [0.97-1.07],0.419489646233653,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,10,1.02 [0.97-1.07],0.42027166167885,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,HIP1R,Huntingtin-interacting protein 1-related protein,Inverse variance weighted,10,0.98 [0.94-1.03],0.421580508030334,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,10,0.98 [0.92-1.04],0.423403396835082,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MSMB,Beta-microseminoprotein,Inverse variance weighted,10,1.01 [0.98-1.04],0.426302263418088,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PREB,Prolactin regulatory element-binding protein,Inverse variance weighted,10,1.02 [0.97-1.07],0.426366287827375,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SLC39A14,Zinc transporter ZIP14,Inverse variance weighted,10,1.02 [0.97-1.06],0.427555548762594,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EDN1,Endothelin-1,Inverse variance weighted,10,0.97 [0.91-1.04],0.428356705816146,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,10,0.98 [0.94-1.03],0.430132375642382,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NUCB2,Nucleobindin-2,Inverse variance weighted,10,1.02 [0.97-1.07],0.431023499864833,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RNASET2,Ribonuclease T2,Inverse variance weighted,10,1.02 [0.98-1.06],0.432840284631682,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD83,CD83 antigen,Inverse variance weighted,10,0.98 [0.92-1.04],0.434447259116318,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,10,1.02 [0.97-1.06],0.437257487566935,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD59,CD59 glycoprotein,Inverse variance weighted,10,1.02 [0.97-1.07],0.439746201130765,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LGALS4,Galectin-4,Inverse variance weighted,10,1.02 [0.97-1.06],0.440628690374153,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,10,0.98 [0.94-1.03],0.442228267141059,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,10,0.99 [0.95-1.02],0.445965887645019,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PENK,Proenkephalin-A,Inverse variance weighted,10,1.02 [0.97-1.07],0.448670160580307,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CALCA,Calcitonin,Inverse variance weighted,10,0.98 [0.94-1.03],0.44898427258462,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCL3,C-C motif chemokine 3,Inverse variance weighted,10,0.98 [0.94-1.03],0.454359412434966,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CLMP,CXADR-like membrane protein,Inverse variance weighted,10,0.98 [0.93-1.03],0.454914937289892,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FABP4,"Fatty acid-binding protein, adipocyte",Inverse variance weighted,10,0.98 [0.95-1.03],0.456431966923322,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,0.98 [0.92-1.04],0.459014559465331,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,10,0.98 [0.92-1.04],0.461687591925476,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCL23,C-C motif chemokine 23,Inverse variance weighted,10,1.02 [0.97-1.06],0.468667420000521,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,10,1.02 [0.97-1.06],0.468710472327714,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,1.02 [0.97-1.06],0.471304303075348,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,VIT,Vitrin,Inverse variance weighted,10,1.01 [0.98-1.05],0.471895563114466,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,10,1.02 [0.97-1.06],0.473998888972587,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,0.98 [0.94-1.03],0.483187859308158,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CFD,Complement factor D,Inverse variance weighted,10,0.98 [0.92-1.04],0.483825520382958,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,10,1.02 [0.97-1.06],0.485373184207562,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,VASN,Vasorin,Inverse variance weighted,10,0.98 [0.94-1.03],0.48871621916638,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,10,0.98 [0.94-1.03],0.494604448918604,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,10,0.98 [0.93-1.03],0.496474010357203,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GHRL,Appetite-regulating hormone,Inverse variance weighted,10,0.98 [0.92-1.04],0.499969306433888,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,10,0.99 [0.94-1.03],0.50023604132832,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,1.02 [0.97-1.06],0.500946797087077,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,10,0.98 [0.94-1.03],0.501245492201433,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,10,0.98 [0.94-1.03],0.502987576370796,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MYL3,Myosin light chain 3,Inverse variance weighted,10,0.99 [0.95-1.03],0.503807598746814,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,10,1.01 [0.97-1.05],0.505775638225428,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CDH1,Cadherin-1,Inverse variance weighted,10,0.98 [0.94-1.03],0.506702981771466,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,10,0.99 [0.95-1.03],0.507752661966001,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CLEC4G,C-type lectin domain family 4 member G,Inverse variance weighted,10,0.99 [0.94-1.03],0.510515692326925,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,10,0.99 [0.95-1.03],0.515082316998919,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,10,0.99 [0.95-1.03],0.516806254954137,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LGALS9,Galectin-9,Inverse variance weighted,10,0.99 [0.95-1.03],0.51802453658358,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,0.99 [0.95-1.03],0.524142637611895,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,10,0.99 [0.95-1.03],0.525307149490909,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,10,0.99 [0.94-1.03],0.528750638052745,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Inverse variance weighted,10,0.98 [0.93-1.04],0.531059501662567,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,10,0.99 [0.95-1.03],0.535560694435079,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RSPO1,R-spondin-1,Inverse variance weighted,10,1.01 [0.97-1.06],0.537187775357868,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,10,1.01 [0.97-1.05],0.537990953982705,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SLC39A5,Zinc transporter ZIP5,Inverse variance weighted,10,1.01 [0.97-1.06],0.540356672799737,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,10,0.98 [0.94-1.04],0.54225638244923,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,10,0.99 [0.95-1.03],0.542322899901189,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,10,0.99 [0.95-1.03],0.542798239754735,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RBP5,Retinol-binding protein 5,Inverse variance weighted,10,0.98 [0.94-1.04],0.54705232460274,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,10,1.01 [0.97-1.06],0.547193344307794,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GDF15,Growth/differentiation factor 15,Inverse variance weighted,10,0.99 [0.94-1.03],0.54904822973652,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,1.01 [0.97-1.06],0.549693387502174,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPON1,Spondin-1,Inverse variance weighted,10,1.01 [0.97-1.06],0.552508144176378,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,COLEC12,Collectin-12,Inverse variance weighted,10,0.99 [0.94-1.03],0.553851273897467,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,10,0.99 [0.94-1.03],0.557427680814453,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ACRV1,Acrosomal protein SP-10,Inverse variance weighted,10,0.99 [0.96-1.02],0.558223547391745,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,UNC5D,Netrin receptor UNC5D,Inverse variance weighted,10,1.01 [0.97-1.06],0.563394043738871,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,XG,Glycoprotein Xg,Inverse variance weighted,10,0.99 [0.96-1.02],0.568035282791363,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,10,0.99 [0.94-1.04],0.568239718451633,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,10,0.98 [0.92-1.05],0.571095400257753,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,10,0.99 [0.94-1.03],0.573574515090968,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,10,0.99 [0.95-1.03],0.578925331714252,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LGALS1,Galectin-1,Inverse variance weighted,10,0.98 [0.93-1.04],0.584248041679397,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,10,1.01 [0.97-1.05],0.584741852440599,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,10,0.99 [0.94-1.03],0.585044426731923,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,10,0.99 [0.95-1.03],0.585489488335842,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GPR158,Probable G-protein coupled receptor 158,Inverse variance weighted,10,1.01 [0.97-1.06],0.587776092710609,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,10,0.99 [0.95-1.03],0.588254997637288,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TFF2,Trefoil factor 2,Inverse variance weighted,10,1.02 [0.96-1.08],0.591124097390755,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DSG2,Desmoglein-2,Inverse variance weighted,10,1.01 [0.97-1.06],0.593659236488416,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NEO1,Neogenin,Inverse variance weighted,10,0.99 [0.95-1.03],0.595355217069793,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KIAA0319,Dyslexia-associated protein KIAA0319,Inverse variance weighted,10,1.01 [0.97-1.06],0.598106473537366,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PDIA3,Protein disulfide-isomerase A3,Inverse variance weighted,10,1.02 [0.96-1.08],0.60277856189167,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,10,1.01 [0.97-1.06],0.602923143320118,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,AGRP,Agouti-related protein,Inverse variance weighted,10,1.01 [0.96-1.07],0.607653375272126,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,10,1.01 [0.97-1.05],0.612132291040681,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPARCL1,SPARC-like protein 1,Inverse variance weighted,10,1.01 [0.97-1.05],0.615175847983349,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Inverse variance weighted,10,1.01 [0.97-1.05],0.615977108882351,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,BTN2A1,Butyrophilin subfamily 2 member A1,Inverse variance weighted,10,0.99 [0.94-1.04],0.618606995396819,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,10,0.99 [0.95-1.03],0.624691456464775,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RNASE6,Ribonuclease K6,Inverse variance weighted,10,0.99 [0.93-1.04],0.624998707208608,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RETN,Resistin,Inverse variance weighted,10,0.99 [0.93-1.05],0.626255193324688,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,10,1.01 [0.97-1.06],0.628248258179637,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PTK7,Inactive tyrosine-protein kinase 7,Inverse variance weighted,10,0.99 [0.93-1.04],0.629400563306964,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,10,0.99 [0.95-1.03],0.632653676740605,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,0.99 [0.95-1.04],0.638417315880992,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RBP7,Retinoid-binding protein 7,Inverse variance weighted,10,0.99 [0.95-1.03],0.639658850096799,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GFRA2,GDNF family receptor alpha-2,Inverse variance weighted,10,0.98 [0.92-1.06],0.642168368120916,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,10,1.02 [0.95-1.09],0.643435737485851,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,10,0.99 [0.94-1.04],0.648585313369513,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,10,0.99 [0.94-1.04],0.649403018058883,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,10,0.99 [0.95-1.03],0.650210516534656,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,APOA4,Apolipoprotein A-IV,Inverse variance weighted,10,0.99 [0.95-1.03],0.6528363179035,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RBP2,Retinol-binding protein 2,Inverse variance weighted,10,0.98 [0.91-1.06],0.652969968965803,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NECTIN4,Nectin-4,Inverse variance weighted,10,0.98 [0.92-1.06],0.66556581703698,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,Inverse variance weighted,10,0.99 [0.94-1.04],0.674997892966435,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PRSS8,Prostasin,Inverse variance weighted,10,1.01 [0.97-1.05],0.676068526169865,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCL16,C-C motif chemokine 16,Inverse variance weighted,10,0.99 [0.96-1.03],0.677149153613116,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TMPRSS11D,Transmembrane protease serine 11D,Inverse variance weighted,10,1.02 [0.93-1.11],0.678072729426697,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PDCD1,Programmed cell death protein 1,Inverse variance weighted,10,0.99 [0.95-1.03],0.682174803279285,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,10,0.99 [0.95-1.03],0.682505144081508,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,10,1.01 [0.97-1.05],0.682777828686331,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SEMA3F,Semaphorin-3F,Inverse variance weighted,10,0.99 [0.95-1.03],0.687247035639101,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Inverse variance weighted,10,1.02 [0.94-1.1],0.692341529707425,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PSAP,Prosaposin,Inverse variance weighted,10,1.01 [0.96-1.06],0.693004905152391,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,AGER,Advanced glycosylation end product-specific receptor,Inverse variance weighted,10,0.99 [0.95-1.03],0.693604960587303,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SLAMF8,SLAM family member 8,Inverse variance weighted,10,1.01 [0.97-1.05],0.697142066573022,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,10,0.99 [0.95-1.04],0.697596243286237,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,0.98 [0.91-1.07],0.699661639959327,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KLK11,Kallikrein-11,Inverse variance weighted,10,1.01 [0.96-1.06],0.702735218898518,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,10,0.99 [0.95-1.03],0.703146611107401,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,10,0.99 [0.93-1.05],0.707445294119704,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PSAPL1,Proactivator polypeptide-like 1,Inverse variance weighted,10,0.99 [0.94-1.04],0.708671263211779,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,10,1.02 [0.94-1.1],0.709724287458557,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,10,0.99 [0.93-1.05],0.710956345476996,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,APOA2,Apolipoprotein A-II,Inverse variance weighted,10,0.99 [0.93-1.05],0.713507575132869,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD300A,CMRF35-like molecule 8,Inverse variance weighted,10,0.99 [0.94-1.04],0.715273566752481,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Inverse variance weighted,10,0.99 [0.93-1.05],0.717009093724053,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SCGB1A1,Uteroglobin,Inverse variance weighted,10,1.01 [0.96-1.06],0.719254417465046,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,10,0.99 [0.95-1.03],0.719763131643588,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,10,0.99 [0.95-1.04],0.722357033328089,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,10,0.99 [0.92-1.06],0.722766901549527,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,10,1.01 [0.97-1.05],0.723466958280805,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SYT1,Synaptotagmin-1,Inverse variance weighted,10,0.99 [0.94-1.04],0.730089435936112,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,10,0.99 [0.95-1.04],0.732033497683949,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD300E,CMRF35-like molecule 2,Inverse variance weighted,10,0.99 [0.94-1.04],0.732142480769488,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,10,0.99 [0.94-1.04],0.733217559009621,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SCN4B,Sodium channel subunit beta-4,Inverse variance weighted,10,0.99 [0.95-1.03],0.733668934378027,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,10,1.01 [0.96-1.06],0.737266745241271,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SEPTIN8,Septin-8,Inverse variance weighted,10,1.01 [0.97-1.05],0.738372582042872,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,10,0.99 [0.95-1.03],0.739804356253084,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,0.99 [0.95-1.04],0.740907782185932,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PRSS2,Trypsin-2,Inverse variance weighted,10,1.01 [0.95-1.07],0.744554722374161,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CALB1,Calbindin,Inverse variance weighted,10,0.99 [0.94-1.05],0.745557473374822,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MMP13,Collagenase 3,Inverse variance weighted,10,1.01 [0.96-1.05],0.749450233495513,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,10,1.01 [0.96-1.05],0.750670979314298,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,10,1.01 [0.97-1.05],0.751324647626816,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,10,1.01 [0.96-1.05],0.752034182509292,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CTSZ,Cathepsin Z,Inverse variance weighted,10,1.01 [0.96-1.06],0.752137607137726,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD160,CD160 antigen,Inverse variance weighted,10,1.01 [0.96-1.05],0.753017909747534,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,AHNAK,Neuroblast differentiation-associated protein AHNAK,Inverse variance weighted,10,0.99 [0.95-1.04],0.754515755722078,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,10,0.99 [0.95-1.04],0.755834366527265,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,10,0.99 [0.95-1.04],0.759706985768002,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,REG1B,Lithostathine-1-beta,Inverse variance weighted,10,1.01 [0.93-1.1],0.760889782729634,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,10,0.99 [0.94-1.04],0.761279261807567,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,AGRN,Agrin,Inverse variance weighted,10,0.99 [0.94-1.05],0.761965151653281,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,10,1.01 [0.96-1.05],0.763119834720466,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,REG1A,Lithostathine-1-alpha,Inverse variance weighted,10,1.01 [0.93-1.1],0.763490822247434,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MMP3,Stromelysin-1,Inverse variance weighted,10,0.99 [0.95-1.04],0.765147509032573,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,10,1.01 [0.96-1.06],0.766183754541374,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ULBP2,UL16-binding protein 2,Inverse variance weighted,10,0.99 [0.93-1.05],0.767000273525279,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TFF1,Trefoil factor 1,Inverse variance weighted,10,0.99 [0.94-1.05],0.769908540058444,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,10,0.99 [0.95-1.04],0.770259844090681,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CALB2,Calretinin,Inverse variance weighted,10,1.01 [0.96-1.05],0.774483673097617,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RSPO3,R-spondin-3,Inverse variance weighted,10,0.99 [0.95-1.04],0.777736074182511,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL17C,Interleukin-17C,Inverse variance weighted,10,0.99 [0.95-1.04],0.779923783816899,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EFNA1,Ephrin-A1,Inverse variance weighted,10,0.99 [0.93-1.05],0.782051770471764,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GRN,Progranulin,Inverse variance weighted,10,0.99 [0.95-1.04],0.783658069091894,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,10,0.99 [0.92-1.07],0.783716374318569,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,AREG,Amphiregulin,Inverse variance weighted,10,0.99 [0.95-1.04],0.788916396061628,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DRAXIN,Draxin,Inverse variance weighted,10,1.01 [0.96-1.05],0.789027268510789,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FGF21,Fibroblast growth factor 21,Inverse variance weighted,10,0.99 [0.93-1.05],0.790375347127582,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,INHBB,Inhibin beta B chain,Inverse variance weighted,10,1.01 [0.96-1.05],0.808878481198228,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCL15,C-C motif chemokine 15,Inverse variance weighted,10,1 [0.97-1.04],0.809698148363321,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,10,1 [0.97-1.05],0.813296656133697,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,10,0.99 [0.94-1.05],0.81787434399856,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ANG,Angiogenin,Inverse variance weighted,10,1 [0.96-1.03],0.818085275334936,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,0.99 [0.95-1.04],0.818360090725182,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,10,0.99 [0.93-1.05],0.81854445608325,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NRP1,Neuropilin-1,Inverse variance weighted,10,1 [0.95-1.04],0.818996885863431,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,10,0.99 [0.94-1.05],0.820435860152224,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CHGA,Chromogranin-A,Inverse variance weighted,10,1 [0.96-1.05],0.821557423603654,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RNASE4,Ribonuclease 4,Inverse variance weighted,10,0.99 [0.94-1.05],0.824067656323707,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,10,1 [0.95-1.04],0.826255603644014,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,XCL1,Lymphotactin,Inverse variance weighted,10,1 [0.97-1.04],0.826327840937377,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,10,0.99 [0.93-1.06],0.826466523196523,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LCN15,Lipocalin-15,Inverse variance weighted,10,0.99 [0.94-1.05],0.828226158784693,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,10,1 [0.95-1.04],0.829921073271771,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TFF3,Trefoil factor 3,Inverse variance weighted,10,1 [0.96-1.05],0.831122702247923,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,10,1 [0.96-1.05],0.833181646803244,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CCL14,C-C motif chemokine 14,Inverse variance weighted,10,1 [0.96-1.05],0.834583898653828,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NEFL,Neurofilament light polypeptide,Inverse variance weighted,10,1 [0.96-1.04],0.840353127292327,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPINK5,Serine protease inhibitor Kazal-type 5,Inverse variance weighted,10,0.99 [0.94-1.05],0.842360378277823,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PRELP,Prolargin,Inverse variance weighted,10,1 [0.96-1.04],0.846372768510191,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,10,1 [0.95-1.04],0.846564222148917,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,1 [0.95-1.05],0.847234853431388,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FOLR1,Folate receptor alpha,Inverse variance weighted,10,1.01 [0.94-1.08],0.849023607138986,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KLK8,Kallikrein-8,Inverse variance weighted,10,0.99 [0.93-1.07],0.849998549212676,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SEZ6L,Seizure 6-like protein,Inverse variance weighted,10,1 [0.96-1.04],0.852751449358316,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PTPRR,Receptor-type tyrosine-protein phosphatase R,Inverse variance weighted,10,1 [0.95-1.04],0.853918879382705,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,10,0.99 [0.94-1.05],0.854755051740846,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RTBDN,Retbindin,Inverse variance weighted,10,1.01 [0.94-1.08],0.857424389656895,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IMMT,MICOS complex subunit MIC60,Inverse variance weighted,10,1.01 [0.95-1.06],0.858633244087695,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,10,1 [0.96-1.05],0.861502141175645,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,10,0.99 [0.93-1.06],0.863462772454989,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,10,1 [0.96-1.05],0.865317546359646,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CA4,Carbonic anhydrase 4,Inverse variance weighted,10,1 [0.95-1.06],0.867293481358302,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SPRR3,Small proline-rich protein 3,Inverse variance weighted,10,0.99 [0.94-1.06],0.8701795977556,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1 [0.94-1.05],0.873605628019012,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,10,1.01 [0.93-1.08],0.874332652775714,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,10,1 [0.95-1.04],0.875253535576562,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,10,1 [0.96-1.05],0.875720963427597,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DPY30,Protein dpy-30 homolog,Inverse variance weighted,10,1 [0.96-1.05],0.881108599272935,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,VCAN,Versican core protein,Inverse variance weighted,10,1 [0.97-1.04],0.882742526703211,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DTNB,Dystrobrevin beta,Inverse variance weighted,10,1 [0.96-1.04],0.884701494481482,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,10,1 [0.96-1.03],0.885095517494128,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PGA4,Pepsin A-4,Inverse variance weighted,10,1 [0.95-1.04],0.88853466342618,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,1 [0.94-1.07],0.889995559652187,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TREML2,Trem-like transcript 2 protein,Inverse variance weighted,10,1 [0.96-1.05],0.890884447365077,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,THBD,Thrombomodulin,Inverse variance weighted,10,1 [0.96-1.04],0.893394658099316,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,10,1 [0.95-1.05],0.89536302572707,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ACTA2,"Actin, aortic smooth muscle",Inverse variance weighted,10,1 [0.96-1.04],0.896893256672918,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PLIN3,Perilipin-3,Inverse variance weighted,10,1 [0.96-1.05],0.897067989712636,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,10,1 [0.95-1.05],0.902402699574881,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,IL19,Interleukin-19,Inverse variance weighted,10,1 [0.94-1.07],0.906748475768788,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SEL1L,Protein sel-1 homolog 1,Inverse variance weighted,10,1 [0.96-1.05],0.907722597771216,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,10,1 [0.96-1.04],0.911092827558706,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FAM3C,Protein FAM3C,Inverse variance weighted,10,1 [0.95-1.06],0.91141340196112,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FAM3B,Protein FAM3B,Inverse variance weighted,10,1 [0.95-1.05],0.911880406181492,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SOX9,Transcription factor SOX-9,Inverse variance weighted,10,1 [0.95-1.04],0.913132155668962,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,10,1 [0.96-1.04],0.915977611908884,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ANXA5,Annexin A5,Inverse variance weighted,10,1 [0.96-1.05],0.916609645122569,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,10,1 [0.96-1.04],0.917110081507889,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,10,1 [0.95-1.05],0.918825370479153,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,WNT9A,Protein Wnt-9a,Inverse variance weighted,10,1 [0.96-1.04],0.918954813481657,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,1 [0.95-1.04],0.921335974179753,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,10,1 [0.96-1.05],0.921973421268712,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,10,1 [0.96-1.04],0.935251036098468,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,10,1 [0.96-1.04],0.937314855462624,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CD46,Membrane cofactor protein,Inverse variance weighted,10,1 [0.96-1.05],0.938258659102793,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,S100G,Protein S100-G,Inverse variance weighted,10,1 [0.95-1.06],0.940249832349858,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,10,1 [0.95-1.05],0.940326100362703,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NECTIN2,Nectin-2,Inverse variance weighted,10,1 [0.96-1.05],0.943143296951646,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,RTN4R,Reticulon-4 receptor,Inverse variance weighted,10,1 [0.96-1.04],0.945575054910823,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CHGB,Secretogranin-1,Inverse variance weighted,10,1 [0.96-1.04],0.946882617189358,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,LAYN,Layilin,Inverse variance weighted,10,1 [0.95-1.05],0.947031591197159,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,DSG3,Desmoglein-3,Inverse variance weighted,10,1 [0.94-1.06],0.949453474215191,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,10,1 [0.96-1.05],0.949646791876948,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MLN,Promotilin,Inverse variance weighted,10,1 [0.94-1.06],0.949905135013255,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,REN,Renin,Inverse variance weighted,10,1 [0.96-1.05],0.94995017960659,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,ALCAM,CD166 antigen,Inverse variance weighted,10,1 [0.94-1.06],0.95416528380803,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FAM3D,Protein FAM3D,Inverse variance weighted,10,1 [0.96-1.04],0.95538445759852,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,10,1 [0.95-1.05],0.95624948504451,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,10,1 [0.96-1.05],0.957971315961676,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,Inverse variance weighted,10,1 [0.96-1.05],0.959249788367967,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,10,1 [0.96-1.04],0.959334383084268,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MMP7,Matrilysin,Inverse variance weighted,10,1 [0.94-1.06],0.963006006809794,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1 [0.96-1.04],0.965034155202761,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,10,1 [0.96-1.04],0.967507688731454,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,10,1 [0.95-1.05],0.967829303597965,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,EFNA4,Ephrin-A4,Inverse variance weighted,10,1 [0.96-1.04],0.971703667834353,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,10,1 [0.96-1.04],0.972267390162773,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,10,1 [0.95-1.05],0.978485888526208,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,10,1 [0.94-1.06],0.979716826318959,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,10,1 [0.94-1.07],0.981276340828715,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,CYTL1,Cytokine-like protein 1,Inverse variance weighted,10,1 [0.96-1.05],0.988156900013396,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,MMP10,Stromelysin-2,Inverse variance weighted,10,1 [0.95-1.05],0.988905515609323,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,10,1 [0.96-1.05],0.989391293834254,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,SNRPB2,U2 small nuclear ribonucleoprotein B'',Inverse variance weighted,10,1 [0.96-1.04],0.993812498557196,trans
